NEUE BENZENSULFONAMIDTHIAZOLVERBINDUNGEN

European patent · EP2917190 · In force

Register entry

Publication number
EP2917190
Application number
EP13792631
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 8, 2013
Published
Sep 16, 2015
Granted
Jul 19, 2017
Protection ends at the latest
Nov 7, 2033
Next annual fee due
Nov 30, 2026
IPC classes
C07D 277/46 (2006.01)
A61K 31/426 (2006.01)
A61P 35/00 (2006.01)
Priority
EP 12306391 09.11.2012
PCT application
PCT/EP2013/073439 08.11.2013
PCT publication
WO2014/072486 15.05.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Jul 19, 2017

    Granted

    Published in Swissreg on 19.07.2017

Parties

Holder

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Institut National de la Santé et de la Recherche Médicale (INSERM)

101, rue de Tolbiac, 75013 Paris, FR

Université Nice - Sophia Antipolis

Université Nice Sophia Antipolis

Grand Château Parc Valrose 28, Avenue Valrose, 06103 Nice Cedex 2, FR

Centre National de la Recherche Scientifique (C.N.R.S.)

3, rue Michel-Ange, 75016 Paris, FR

Inventor

ROCCHI, Stéphane

F-06204 Nice Cedex3, FR

BALLOTTI, Robert

F-06204 Nice Cedex3, FR

BENHIDA, Rachid

F-06108 Nice Cedex 2, FR

CEREZO, Michael

F-06204 Nice Cedex 3, FR

DUCA, Maria

F-06108 Nice Cedex 2, FR

JOLY, Jean-Patrick

F-06108 Nice Cedex 2, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.